Nurix Therapeutics, Inc. · NASDAQ:NRIX

Hansen Gwenn sold 3,847 Nurix Therapeutics, Inc. shares (Form 4)

Traded Jul 30, 2026 · Filed Jul 30, 2026

On Jul 30, 2026, Hansen Gwenn (Chief Scientific Officer) sold 3,847 Nurix Therapeutics, Inc. shares at US$23.38 for US$89,943, leaving 121,338 shares. Filed Jul 30, 2026 (Form 4).

Sold
3,847 shares
Price
US$23.38
Value
US$89,943
Holding after
121,338 shares
Trading plan
No
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 30, 2026Common StockOption exercise3,750118,755Direct
Jul 30, 2026Common StockOption exercise2,858121,613Direct
Jul 30, 2026Common StockOption exercise3,572125,185Direct
Jul 30, 2026Common StockSale3,847US$23.38121,338Direct

Source

View original at SEC

Related